Live market screen
Commercial Space Company Risk / Opportunity Ranking
Opportunity/risk view across launch, satellites, SAR, earth observation, defense demand, financing events, and execution risk.
Updated June 27, 2026
Opportunity view
Showing rows 161-180 of 438; 20 rows per page.
| Rank | Company | Score | Thesis / Evidence |
|---|---|---|---|
| 161 | Antaris Inc. lowweak | Opp 2 Risk 2 | Thesis: Antaris may have strategic opportunity based on the membership rationale referencing private space software work, LEO ISR/optical communications architecture, a JANUS-2 mission, and self-healing satellite capability for the U.S. Space Force, but the reviewed sources includes no retained recent evidence window-window evidence to support scoring that thesis now. Why now: There is no retained 90-day evidence in these reviewed sources despite references to evidence in earlier processing. Recency-sensitive conclusions therefore cannot be made from the local reviewed sources. Caveats: Membership rationale references older evidence but no article IDs are provided with accessible summaries in these reviewed sources body. No representative articles or retained evidence are included. Low score reflects evidence absence, not a negative business judgment. |
| 162 | Antaris Inc. lowweak | Opp 2 Risk 1 | Thesis: There is a faint opportunity signal because the phase2 rationale states Antaris appeared as part of an investment issuer's portfolio after a $28 million Series A, which suggests access to capital, but the reviewed sources does not provide the underlying citable event text in the scoring evidence fields. Why now: Why now is weak: the only reviewed sources signal is the phase2 rationale mentioning a post-Series A portfolio reference tied to article, but no representative article summary or direct evidence row is included here to establish timing or business impact. Caveats: The cited Series A context appears only in phase2 rationale rather than in stronger scoring evidence fields. No product, customer, or execution evidence is provided. |
| 163 | Applied Atomics lowweak | Opp 2 Risk 3 | Thesis: Applied Atomics may have long-horizon optionality as a startup developing in-space mobility/orbital logistics concepts, but the reviewed sources provide no available article or evidence inside the recent evidence window to support a stronger opportunity score. Why now: There is no available dated evidence in the reviewed sources after recent evidence filtering, so recency-based ranking support is weak. Caveats: No representative articles or evidence are available after recent evidence filtering for ranking support. The phase2 membership rationale mentions a $4M pre-seed and Star Reacher Network, but the cited supporting articles are not provided with usable article summaries or evidence in these reviewed sources. |
| 164 | Astranis Space Technologies lowweak | Opp 2 Risk 2 | Thesis: Phase-2 rationale states Astranis was selected by the U.S. Space Force for the Andromeda contract for next-generation space domain awareness/surveillance satellites, which would be positive if current and retained, but the present reviewed sources contain no in-window evidence to substantiate it. Why now: The current batch retains no representative articles or evidence within the 90-day recent evidence window for Astranis, so the reviewed sources does not provide a current dated catalyst despite the phase-2 rationale. Caveats: No retained evidence after recent evidence window. Phase-2 rationale mentions duplicate article versions; duplicates would not be independent confirmation anyway. |
| 165 | Astrobotic Technology lowweak | Opp 2 Risk 2 | Thesis: The membership rationale says Astrobotic operates the Griffin lunar lander and is a CLPS contractor, which is strategically relevant for a 1 year+ horizon, but the reviewed sources supplies no available within the recent evidence window direct positive evidence or dated article summaries for scoring. Why now: The rationale references articles, and: but no corresponding available evidence remains available for direct scoring after recent evidence filtering. Caveats: Lunar lander category fit does not equal thesis attractiveness. Coverage debug shows zero available evidence after recent evidence window. Without direct execution, funding, contract-conversion, or mission-status evidence, scores should remain conservative. |
| 166 | Astrolight lowweak | Opp 2 Risk 1 | Thesis: Membership rationale indicates Astrolight is a private space/defense startup developing laser communication terminals for space, with ESA contracts and deployed terminals, which could support a 1 year+ growth thesis in optical communications if verified by direct evidence. Why now: Why now is weak because the reviewed sources cites support article: in membership rationale, but no, article summary, or retained evidence are provided after the 90-day filter. Caveats: Potentially strong fundamentals are only referenced in membership rationale without citable article details. Coverage data shows zero articles after recent evidence window and zero evidence after recent evidence window. Private-company status also limits external validation in these reviewed sources. |
| 167 | Astrolight UAB lowweak | Opp 2 Risk 2 | Thesis: Astrolight UAB may have a long-horizon opportunity if it is providing optical hardware into a Kepler Communications ESA HydRON optical communications network effort, but the reviewed sources lack available direct evidence to confirm Astrolight's own contract position, scope, or recency. Why now: There is no usable 'why now' beyond possible strategic relevance to optical communications. The reviewed sources provide no after-recent evidence window evidence to confirm current status. Caveats: Phase-2 rationale references, but the reviewed sources does not include its or article summary. Relations marked context-only cannot be used as counterparty propagation evidence. Coverage debug shows zero evidence after recent evidence window. |
| 168 | Astrome lowweak | Opp 2 Risk 1 | Thesis: Reviewed evidence rationale says Astrome was among spacetech startups receiving India's RDI fund support, which is directionally positive as non-dilutive or supportive capital context, but no underlying article or dated event evidence is present in the available recent evidence window dataset. Why now: Why now is weak because the support exists only in the phase-2 rationale; coverage data shows zero evidence after recent evidence window, so timing and durability of the funding support cannot be verified from local evidence. Caveats: No direct article or event evidence is available after recent evidence window. Government-support statement is not accompanied by a dated in-window source in the reviewed sources. Low confidence due to sparse evidence. |
| 169 | Atomos Space lowweak | Opp 2 Risk 1 | Thesis: A very modest opportunity case exists only because retained undated supporting context lists Atomos Space as an operating in-orbit servicing company, which at least suggests ongoing activity in a strategically relevant segment, but this is supporting article context rather than direct company event evidence. Why now: Why now is limited and recency is uncertain: the only retained evidence is undated supporting context, so it cannot establish a fresh catalyst, only background relevance, article date_basis: undated). Evidence
Caveats: The evidence is undated, and the reviewed sources explicitly says to treat undated external evidence as relevance context rather than recency proof. The retained rows are weak context and neutral polarity, not positive evidence. Same article repeated rows are not independent confirmation. |
| 170 | Azista Space lowweak | Opp 2 Risk 2 | Thesis: Reviewed evidence membership rationale says Azista Space built the satellite bus/payload for GalaxEye's Drishti Earth Observation Satellite, which implies real manufacturing participation and possible long-horizon opportunity, but no direct evidence or article are available in the served reviewed sources. Why now: Why now is weak because there is no surviving 90-day evidence row in the reviewed sources to establish recency or momentum. Caveats: Only membership rationale is available; no citeable direct evidence with are provided. Single-article universe increases fragility of inference. |
| 171 | Blackstar Orbital lowweak | Opp 2 Risk 2 | Thesis: The reviewed sources rationale suggests Blackstar Orbital is described as a hypersonic/reusable spacecraft testing partner with mention of a reusable hypersonic satellite concept, which could imply technology optionality if substantiated and, no provided in reviewed sources). However, the evidence retained here is not direct and no positive events are available after recent evidence window. Why now: No near-term or durable catalyst can be established from retained evidence because coverage debug shows zero article IDs and zero evidence after recent evidence window. Caveats: No are provided for the cited support articles in the reviewed sources. The reviewed sources explicitly characterizes the evidence as mostly partnership context rather than direct operating detail. Coverage debug shows articles after recent evidence window = 0 and evidence after recent evidence window = 0. |
| 172 | Brightside Group S.A. lowweak | Opp 2 Risk 2 | Thesis: Membership rationale indicates Brightside is advancing a €415M sovereign satellite program and provides a sovereign satellite platform via partnership with SES, which could be meaningful if current, but the reviewed sources exposes no direct within the recent evidence window evidence or article summaries to substantiate a current opportunity thesis. Why now: Why now is weak because no representative article or direct evidence survives in the ranking fields after recent evidence window; only membership rationale references without surfaced article content. Caveats: No direct within the recent evidence window evidence is available in ranking fields. Membership rationale alone is weaker than surfaced company-specific event evidence. No negative thesis is supportable from the reviewed sources. |
| 173 | BULL Co., Ltd. lowweak | Opp 2 Risk 1 | Thesis: The membership rationale says BULL signed an agreement with Fujitsu to develop a high-precision space situational awareness service for Japan, which is directionally positive, but there is no retained within the recent evidence window article evidence or in the reviewed sources to support a stronger opportunity thesis. Why now: No within the recent evidence window evidence were retained, so there is no strong timing signal for a 1 year+ ranking beyond weak membership context. Caveats: Membership rationale references articles and, but the reviewed sources does not provide or retained evidence. Potential commercial significance cannot be sized from the reviewed sources. |
| 174 | Calian Group Ltd. lowweak | Opp 2 Risk 1 | Thesis: There is some older membership support that the Canadian Space Agency awarded Calian funds for RADARSAT+ ground-segment concept studies via article: which could indicate space-contract relevance, but no retained in-window evidence with supports a stronger current opportunity thesis. Why now: Why now is weak because the reviewed sources retained no evidence after recent evidence window for Calian, so no current catalyst is evidenced. Caveats: Reviewed evidence mentions: but provides no, preventing direct citation as scored evidence. No retained 90-day evidence. Opportunity case depends on uncited older context rather than current business-state confirmation. |
| 175 | CAS Space lowweak | Opp 2 Risk 3 | Thesis: CAS Space may have long-horizon opportunity as a reusable rocket developer and launch provider, but the ranking reviewed sources provide no available supporting evidence within the recent evidence window. Why now: There is no usable dated evidence available after recent evidence filtering, so the reviewed sources does not provide a clear timing catalyst. Caveats: The membership rationale references an IPO and Lijian-1 launch activity, but those source articles are not included with ranking-usable details in these reviewed sources. |
| 176 | CAS Space lowweak | Opp 2 Risk 2 | Thesis: The reviewed sources rationale says CAS Space is among Chinese rocket/satellite companies advancing IPO or pre-IPO plans, which could be a strategic opportunity signal if supported by company-specific evidence (: and: no provided in reviewed sources). Why now: There is no verified current catalyst in retained evidence. IPO/pre-IPO framing could matter on a 1 year+ horizon, but recency and milestone state cannot be confirmed here because no dated evidence are available after recent evidence window. Caveats: No are provided for the cited support articles in the reviewed sources. Coverage debug shows articles after recent evidence window = 0 and evidence after recent evidence window = 0. IPO/pre-IPO mention is only in reviewed sources rationale, not in retained direct evidence. |
| 177 | Citra Space Corp lowweak | Opp 2 Risk 1 | Thesis: The membership rationale says Citra Space raised a $15M Series A to advance space object identification technology, which would ordinarily be positive, but the reviewed sources provide no retained within the recent evidence window article evidence or to ground a stronger opportunity call. Why now: There is no usable within the recent evidence window article evidence available for ranking; coverage data shows zero article IDs after recent evidence window and zero evidence after recent evidence window, so any current catalyst judgment would be speculative. Caveats: Membership rationale references article, but the reviewed sources does not provide the article or retained ranking evidence inside the recent evidence window. Because direct evidence arrays are empty, the small positive score reflects only weak contextual possibility, not high-confidence attractiveness. |
| 178 | Cosmoserve Space lowweak | Opp 2 Risk 2 | Thesis: Reviewed evidence membership rationale says Cosmoserve Space is a private space sustainability company working on debris removal, with Pixxel providing a satellite bus for its demo mission. That suggests a real mission path, but there are no citeable direct evidence or in the served reviewed sources. Why now: Why now is weak because the reviewed sources does not establish current demo timing or funding status with direct evidence after recent evidence window. Caveats: Private company with thin visible evidence in these reviewed sources. Mission/demo status cannot be validated from available evidence. |
| 179 | Curtiss-Wright Corporation lowweak | Opp 2 Risk 1 | Thesis: Curtiss-Wright has modest contextual opportunity because the membership rationale describes it as a ruggedized electronics supplier benefiting from broader space spending, which could align with a durable 1 year+ strategic cycle if backed by company-specific orders or segment growth evidence (: unavailable in reviewed sources). But the reviewed sources contain no direct positive evidence within the recent evidence window. Why now: Potentially relevant if broader space spending is increasing, but the reviewed sources provide no retained dated evidence, no current data, so timing and magnitude cannot be validated. Caveats: No current evidence is provided for Relation/context evidence must not be used as counterparty propagation; reviewed sources notes context only. No available direct evidence after recent evidence window despite high article count considered. |
| 180 | Deloitte lowweak | Opp 2 Risk 1 | Thesis: There is some indication of meaningful space activity, but not enough retained direct evidence to make a strong 1 year+ opportunity call. Why now: The reviewed sources rationale says Deloitte launched satellites for Project Constellation to test on-orbit cyber protections and contracted Spire to design, build, and operate satellites, citing article, but no or retained evidence row is available after recent evidence window, limiting confidence. Caveats: The described activity comes only from membership rationale rather than retained evidence. Without retained dated evidence or, chronology and durability cannot be tested. |
Risk view
Showing rows 161-180 of 438; 20 rows per page.
| Rank | Company | Score | Thesis / Evidence |
|---|---|---|---|
| 161 | HawkEye 360, Inc. lowweak | Opp 2 Risk 2 | Thesis: The reviewed sources lack direct positive or negative company-specific in-window operating evidence; the only retained article is weak supporting article context. That makes both upside and downside hard to validate, and uncertainty itself is the main risk. Why now: The only retained dated item is an April 5, 2026 supporting article context entry stating HawkEye 360 is a data analytics company developing space-based radio frequency mapping and a satellite constellation startup: That is too weak to establish a strong current catalyst. Caveats: Only weak supporting article context is retained after recent evidence window; no direct event/fact evidence is available. Phase2 rationale mentions 30+ satellites and government contracts, but the reviewed sources does not provide those source articles in detail here. |
| 162 | HEO lowweak | Opp 3 Risk 2 | Thesis: Risk is mainly evidentiary: the reviewed sources lack direct dated operating, financing, execution, or customer-conversion evidence, so business durability and current momentum are unclear. Why now: Why now is weak because both cited items are undated, so the reviewed sources does not establish a fresh catalyst within the current evidence window. The only support is that HEO appears in current reviewed sources context as an operating company and as associated with a contract mention, but recency cannot be confirmed from the reviewed sources Evidence
Caveats: Both supporting items are undated, so recency is uncertain. Support is supporting article context, not stronger company-specific dated event evidence. Same-article repeated rows in the reviewed sources are not independent confirmation. |
| 163 | Hispasat lowweak | Opp 4 Risk 2 | Thesis: The reviewed sources does not provide retained in-window article detail on contract economics, implementation timing, or execution risk, so the business significance cannot be scored aggressively and no direct adverse evidence is shown. Why now: The only timing clue is the membership rationale referencing article, but the underlying article summary and are not included in these reviewed sources. Recency beyond the batch month label is uncertain. Caveats: No representative article or is available in the reviewed sources despite the favorable rationale. Program-role evidence can be important, but without economics or milestones the opportunity case is incomplete. |
| 164 | HughesNet lowweak | Opp 1 Risk 2 | Thesis: Risk is mostly evidence absence rather than confirmed adverse developments: despite 104 considered articles, the reviewed sources loads zero direct negative or positive rows after recent evidence window, leaving business-state, financing, competitive, and operational risks unresolved. Why now: There is no validated near-term or long-term catalyst from active evidence. The reviewed sources cites article in membership support, but the company coverage section shows zero articles after recent evidence window and zero evidence after recent evidence window, so recency-backed thesis formation is not possible. Caveats: High article count does not equal conviction; no post-recent evidence window evidence was available. No direct company-specific event/fact evidence is available in the output reviewed sources. |
| 165 | Institute for Q-shu Pioneers of Space, Inc (iQPS) lowweak | Opp 3 Risk 2 | Thesis: No direct negative evidence is available. Residual risk comes from limited evidence depth in the ranking reviewed sources and the lack of direct operating, financing, or customer traction details after recent evidence window. Why now: Why now is only modest because launch-linked deployment could matter over a long horizon, but there are no available article summaries or dated events to establish current momentum. Caveats: Membership rationale references article IDs and, but no or summaries are provided. No direct evidence survived or were available into these reviewed sources after recent evidence window. Do not use relation context as counterparty propagation evidence. |
| 166 | Intelsat General lowweak | Opp 2 Risk 2 | Thesis: No material adverse evidence is available in the local reviewed sources, but absence of current direct evidence also prevents a strong positive thesis. Why now: Why-now support is weak because coverage data shows zero article/evidence after the 90-day recent evidence window, so recency for the cited contract context cannot be validated from available evidence. Caveats: Phase2 membership rationale references: but no representative article or evidence row is available after recent evidence window for direct citation. Coverage data reports articles after recent evidence window = 0 and evidence after recent evidence window = 0. Scored low due to evidence absence, not due to negative business evidence. |
| 167 | Jacobs lowweak | Opp 2 Risk 2 | Thesis: There is no material adverse evidence. Risk is low-to-moderate only because current reviewed sources evidence is stale for the selected recent evidence window, not because of a negative event. Why now: Why now is weak because the contract evidence is older. The reviewed sources cites Space Force and SpaceNews articles dated June 3, 2025, which are outside the 90-day evidence window Caveats: Contract evidence exists but falls outside the selected 90-day recent evidence window. No direct positive or negative evidence remain after recent evidence filtering. |
| 168 | Jio Platforms lowweak | Opp 2 Risk 2 | Thesis: Because the reviewed sources frames Jio's satellite effort as planned and early-stage, execution and timing risk are meaningful, but the reviewed sources still lacks direct adverse evidence to score risk highly. Why now: Why now is not well supported in the served evidence because no representative articles or direct evidence are available after recent evidence window despite the membership rationale referencing article IDs, and Caveats: No representative articles or direct evidence are included in the reviewed sources output. Membership rationale is not a substitute for direct thesis evidence. Recency and event sequence cannot be judged from the missing article details. |
| 169 | K2 Space mediummedium | Opp 5 Risk 2 | Thesis: The main risk is evidence quality rather than a documented adverse event: the reviewed sources classifies the available support as weak supporting article context with neutral polarity and no direct positive or negative dated event/facts, limiting confidence in both upside magnitude and downside assessment. Why now: The evidence is recent within the 90-day recent evidence window and dated June 11, 2026 on a source date basis, which fits a 1 year+ horizon because supplier-role wins in defense satcom can matter over a longer program cycle if they convert into execution and revenue-bearing milestones. Evidence
Caveats: Available support is supporting article context with neutral polarity, not direct structured positive event/fact evidence. Only one dated article remains within the recent evidence window; same-article repeated rows are not independent confirmation. |
| 170 | Kepler Communications lowweak | Opp 3 Risk 2 | Thesis: Opportunity remains speculative because the reviewed sources offers only contextual support and no available company-specific event or fact evidence after recent evidence window; customer traction, contract value, deployment status, and monetization are not confirmed. Why now: The reviewed sources references, and: in membership support, suggesting recent strategic context, but no post-recent evidence window evidence are actually available for scoring. Caveats: Reviewed evidence itself says support is somewhat contextual. Context-only references are weaker than direct event/fact evidence. No available evidence confirms deployment, revenue, or funding milestones. |
| 171 | Korea Aerospace Industries (KAI) lowweak | Opp 2 Risk 2 | Thesis: No material adverse evidence is present in the reviewed sources. Risk is low-to-moderate only because the evidence set is empty after recent evidence window, so there is insufficient support for either a strong positive or negative thesis. Why now: Why now is weak because the reviewed sources say one article supported membership, article ID: but no, timing detail, or direct evidence were available after recent evidence window. Caveats: No direct evidence or article summaries were available after recent evidence window. Membership support references article ID: without a in the reviewed sources. |
| 172 | LiveEO lowweak | Opp 3 Risk 2 | Thesis: No direct negative evidence is provided; risk is mainly that the thesis is under-evidenced in these reviewed sources. Why now: Why-now cannot be established because no evidence remain after recent evidence filtering. Caveats: Phase2 membership rationale references, but no summary or evidence are provided for citation. Coverage debug shows articles after recent evidence window = 0 and evidence after recent evidence window = 0. Low scores reflect missing usable evidence, not a bearish business judgment. |
| 173 | Lockheed Martin mediummedium | Opp 6 Risk 2 | Thesis: The reviewed sources show no direct adverse evidence within the recent evidence window; main risk is that the support here is only supporting article context rather than stronger direct event/facts. Why now: The relevant contract article is dated April 16, 2026, inside the 90-day recent evidence window, and describes current modernization work tied to GPS IIIF support, which can matter over a multi-quarter horizon. Source date: April 16, 2026 Evidence
Caveats: Evidence is supporting article context only; no direct positive event row is available. Same article appears in multiple weak-context rows and does not count as independent confirmation. |
| 174 | Lockheed Martin Corporation lowweak | Opp 2 Risk 2 | Thesis: No material adverse evidence is available in these reviewed sources, but the absence of current direct evidence prevents a strong positive ranking. Why now: There is no available why-now evidence within the 90-day recent evidence window; coverage data shows zero evidence after recent evidence window. Caveats: Phase2 rationale cites, and, but no representative articles or evidence are available in the reviewed sources body for citation. Coverage data reports articles after recent evidence window = 0 and evidence after recent evidence window = 0. Low score reflects insufficient current reviewed sources evidence, not a negative fundamental view. |
| 175 | LSS GmbH lowweak | Opp 1 Risk 2 | Thesis: Primary risk is evidentiary: the reviewed sources does not establish current business traction, financial position, or recent contract progress for LSS GmbH within the recent evidence window, so any positive thesis is highly speculative. Why now: There is no clear 'now' catalyst in the available evidence. The reviewed sources states zero article IDs after recent evidence window and zero evidence available after recent evidence window, so recency is unverified for a 1 year+ ranking. Caveats: Phase-2 rationale references consortium work tied to: and: but the reviewed sources does not include article summaries or for those items. Coverage debug shows zero evidence after recent evidence window, so no direct claim can be validated as current. Cohort review status is not a directional signal. |
| 176 | Lux Aeterna lowweak | Opp 2 Risk 2 | Thesis: Early-stage hardware execution risk is plausible, but the reviewed sources does not provide direct negative evidence inside the recent evidence window, so risk should remain low-scored. Why now: No within the recent evidence window evidence were retained for ranking, so there is no evidence-backed near-term or durable timing edge beyond generic early-stage company progress assumptions. Caveats: Membership rationale references article: but the reviewed sources does not include its or a retained evidence row. |
| 177 | Lynk Global, Inc. lowweak | Opp 2 Risk 2 | Thesis: The reviewed sources does not describe the business model directly, so assessment risk is high; no material adverse event evidence is available after recent evidence filtering. Why now: If a rideshare payload mention reflects program progress, that could matter over 1 year+, but the reviewed sources provide no citable event details, timestamps, quote, or for article ids: and Caveats: A payload mention is more concrete than generic context, but still insufficient here because no direct evidence row or citation is included. No recent evidence window-surviving evidence exists in the reviewed sources. Slight score uplift reflects somewhat more operationally concrete context only. |
| 178 | Mach Industries lowweak | Opp 3 Risk 2 | Thesis: The same rationale also implies category ambiguity: the company is presented primarily as defense tech, so the space thesis may be overstated. No direct adverse event is available; risk is mostly execution and classification uncertainty rather than reviewed sources-proven negative developments (: not provided in reviewed sources). Why now: For a 1 year+ horizon, a large raise and mention of a satellite platform could matter if recent, but the reviewed sources does not provide usable dated evidence within the 90-day recent evidence window and explicitly reports zero available evidence after recent evidence window. Caveats: No article provided in reviewed sources. No direct event/facts are available after recent evidence window despite the membership rationale referencing a raise. Primarily defense-tech framing may limit pure-play space thesis relevance. |
| 179 | Maxar Technologies Inc. lowweak | Opp 3 Risk 2 | Thesis: Risk is mostly evidence-gap risk in these reviewed sources: without retained 90-day evidence, there is no current confirmation of contract timing, backlog conversion, program execution, or adverse developments. Why now: No retained evidence is available within the reviewed sources despite the membership rationale referencing a prior NASA deal article. That makes the name a weak current candidate under local-evidence-only rules. Caveats: No retained article summary or dated event row is provided for the cited NASA deal. Cannot elevate conviction based only on membership rationale. |
| 180 | MBRYONICS Ltd lowweak | Opp 2 Risk 2 | Thesis: The key risk is dependence on indirect role and missing evidence: the reviewed sources does not establish whether MBRYONICS is a prime beneficiary versus a component partner, and no adverse events are documented. Why now: Why now is weak because only a membership rationale references article about participation in an ESA optical communications project led by Kepler Communications, but no article or reviewed evidence is available for ranking citation. Caveats: Relation-style partnership context cannot be overused as directional proof. No article is provided for article. Coverage after recent evidence window is empty. |